A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)

Starting soon · Phase 1

Conditions studied: Healthy

In brief

The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD). Before giving a trial medicine to people with a health condition, researchers first do clinical trials in healthy people. This trial will help researchers learn about the safety of MK-1403 and if participants tolerate it. Tolerate means participants receive the trial medicine and they do not need to stop taking it due to health problems. The trial will also measure what happens to MK 1403 in a healthy person's body over time.

Key facts

Study ID

NCT07677163

Run by

Merck Sharp & Dohme LLC

People needed

15

Starts

2026-07-29

Expected to finish

2026-09-22

Last updated by the study team

2026-06-30

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Is in good health
• Has a body mass index (BMI) ≥ 18 and ≤ 32 kg/m\^2

You may not qualify if…

• Has history of cancer (malignancy)
• Has a history of significant multiple and/or severe allergies

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.